A novel series of enediynes possessing pentafluorophenylsulfoxide have been developed. The innovative compounds possess antiproliferative activity against a broad panel of human cancer cells originating from breast, blood, lung, kidney, colon, prostate, pancreas or skin with IC ranging from 0.6 to 3.4 μM. The antiproliferative activity of enediynes in darkness is associated to their ability to compromise microtubule network. In addition, exposure to UV leads to double-stranded DNA cleavage caused by the newly synthesized molecules reducing further their IC in nanomolar range against human tumor cells, including chemo-resistant pancreatic cancer cells. Taken together, the examined data demonstrate that enediynes possessing pentafluorosulfoxide are promising molecules in the cancer therapy.
Rather
surprisingly, C–C bond formation through “intermolecular”
radical addition to internal ynamides has never been reported. Actually,
ynamides are excellent acceptors for “electrophilic”
carbon-centered radicals. These processes enable the introduction
of functionalized alkyl chains at Cβ, groups that have not yet
been introduced via the addition of organometallics. Radical carboiodination
affords persubstituted α-iodo-enamides in moderate to high yield.
The addition is totally stereoselective. Theoretical support to the
mechanism and the scope and limitation of the reaction are discussed.
Dynamic Nuclear Polarization (DNP) at cryogenic temperatures has proved to be a valuable technique to enhance the sensitivity of solid-state NMR spectroscopy. Over the years, sample formulations have been optimized...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.